Veterinary Medicines

Amos ferrum 20% + B12, oplossing voor injectie voor biggen.

Authorised
  • IRON(III)-HYDROXIDE DEXTRAN COMPLEX
  • Cyanocobalamin
Download as PDF

Product identification

Medicine name:
Amos ferrum 20% + B12, oplossing voor injectie voor biggen.
Active substance:
  • IRON(III)-HYDROXIDE DEXTRAN COMPLEX
  • Cyanocobalamin
Target species:
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • IRON(III)-HYDROXIDE DEXTRAN COMPLEX
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cyanocobalamin
    200.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        no withdrawal period
  • Subcutaneous use
    • Pig
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB03AE10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Kommer-Biopharm B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Feramed B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 8350
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."